Zandra Hagman (Former)
1 – 10 of 10
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2015
- 
                        Mark
        miR-183 in Prostate Cancer Cells Positively Regulates Synthesis and Serum Levels of Prostate-specific Antigen.
    
    - Contribution to journal › Article
 
- 
                        Mark
        miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.
    
    - Contribution to journal › Article
 
- 2013
- 
                        Mark
        miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients.
    
    - Contribution to journal › Article
 
- 
                        Mark
        miQ - a novel microRNA based diagnostic and prognostic tool for prostate cancer.
    
    - Contribution to journal › Article
 
- 
                        Mark
        The tumour suppressor miR-34c targets MET in prostate cancer cells.
    
    - Contribution to journal › Article
 
- 2012
- 
                        Mark
        A microscopic investigation of miR-34c and miR-205 in Prostate Cancer
    
    - Thesis › Doctoral thesis (compilation)
 
- 
                        Mark
        Targeting Free Prostate-Specific Antigen for In Vivo Imaging of Prostate Cancer Using a Monoclonal Antibody Specific for Unique Epitopes Accessible on Free Prostate-Specific Antigen Alone.
    
    - Contribution to journal › Article
 
- 2011
- 
                        Mark
        Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells.
    
    - Contribution to journal › Article
 
- 2010
- 
                        Mark
        Systematic functional analysis of microRNAs by transfection of 1129 miRNAs into prostate cancer cells
    (2010) 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics In EJC Supplements 8(7). p.177-177- Contribution to journal › Published meeting abstract
 
- 
                        Mark
        miR-34c is down regulated in prostate cancer and exerts tumor suppressive functions.
    
    - Contribution to journal › Article
 
